Compare PTCT & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | URBN |
|---|---|---|
| Founded | 1998 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.9B |
| IPO Year | 2006 | 1995 |
| Metric | PTCT | URBN |
|---|---|---|
| Price | $69.04 | $72.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | $80.65 | ★ $86.91 |
| AVG Volume (30 Days) | 733.3K | ★ 1.2M |
| Earning Date | 05-07-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 264.48 | 18.78 |
| EPS | ★ 7.78 | 5.06 |
| Revenue | $264,734,000.00 | ★ $6,165,376,000.00 |
| Revenue This Year | N/A | $10.67 |
| Revenue Next Year | $17.70 | $7.01 |
| P/E Ratio | ★ $8.75 | $14.54 |
| Revenue Growth | ★ 36.19 | 11.07 |
| 52 Week Low | $35.95 | $51.03 |
| 52 Week High | $87.50 | $84.35 |
| Indicator | PTCT | URBN |
|---|---|---|
| Relative Strength Index (RSI) | 48.31 | 58.20 |
| Support Level | $64.00 | $67.04 |
| Resistance Level | $69.23 | $74.12 |
| Average True Range (ATR) | 2.38 | 2.60 |
| MACD | -0.33 | 0.52 |
| Stochastic Oscillator | 25.12 | 61.03 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.